465
Participants
Start Date
September 20, 2019
Primary Completion Date
December 9, 2020
Study Completion Date
December 9, 2020
FluMist live attenuated influenza vaccine
Participants randomized to this study influenza vaccine arm will receive FluMist live attenuated influenza vaccine at baseline after the baseline blood draw is complete.
Flucelvax inactivated influenza vaccine
Participants randomized to this study influenza vaccine arm will receive Flucelvax cell-culture inactivated influenza vaccine at baseline after the baseline blood draw is complete.
General Academic Pediatrics, Pittsburgh
University of Pittsburgh Department of Family Medicine, Pittsburgh
Centers for Disease Control and Prevention
FED
Richard Zimmerman MD
OTHER